-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 18, at the "Future Medical Top 100 Forum" held by Arterial Network, seven enterprises or institutions, including Alibaba Cloud, Deshan Yunxing, Physical Science and Technology, NVIDIA (NVIDIA), Yisseor Medical, Health Benefits, DHIC, etc., carried out new products, financing, reporting, strategy, cooperation and other five directions of the new release.
Among them, Alibaba Cloud released image cloud solutions, from image storage, sharing to intelligence, joint solution provider ecological realization of hospital imaging resources at all levels of sharing, avoid repeated filming, support doctors mobile reading, support patients QR code browsing digital images, build the future of intelligent medical digital imaging services.
It is understood that Alibaba Cloud joint ecological partners from storage, sharing to intelligence, to provide cloud-to-cloud integrated image cloud solutions, can provide a large number of secure storage services, digital images can automatically multi-redundant backup, real-time access to historical images, interregional image connectivity, and so on.
Deshan Yunxing has released an artificial intelligence-assisted diagnostic product for breast cancer. It is reported that the entire research and development process after a large amount of data cleaning and finishing, by senior breast experts in strict accordance with the international ACR standards to personally label the characteristics of the breast extraction, repeated confirmation, to ensure high accuracy.
CEO Ding Xiaowei, who specializes in artificial intelligence and healthcare, announced the completion of a $50 million round of B financing, led by Hongtai Capital, Sequoia Capital, Qingsong Capital, Hanfu Capital and Investment, with Miracle Capital acting as exclusive financial advisors. This round of funds is mainly used for medical imaging AI solution products market access registration and clinical landing.
addition, NVIDIA has launched the CLARA Open Platform. According to Yu Wei, chief architect of medical life sciences in China at NVIDIA, the CLARA platform provides an open, scalable, remote and common platform that converts data stored in medical devices into dynamic medical imaging data. (China Securities News)